$ASEP's multi-billion dollar opportunity ASEP Medical ($ASEP.c) is positioned to capitalize on a multibillion-dollar opportunity with multiple catalysts expected during 2022.
Coming up first is $ASEP's OTC market listing with DTC eligibility in the next couple of weeks under $SEPSF (NASDAQ listing expected 4-6 months after OTC) with FDA 510(k) approval for its diagnostic method expected to follow after.
Check out $ASEP's webinar from March 3rd here: https://tinyurl.com/bdzc3spk